Tweet Archive for June 2016 « page 26
RT @EvidenceLive: How can evidence producers improve practice and policy? – @DavidTovey editor of @cochranecollab evidencelive.org/speaker/david-… #…
RT @OxfordMedSci: #evidencelive 2016 Open meeting to kick starting the campaign for Better Evidence for Better Decisions https://t.co/PXz2N…
RT @practiceupdate: .@ASCO : Pembrolizumab Improves Survival in #Melanoma ow.ly/qtXE300v2I0 #ASCO16 #skcsm
RT @MDAMelanomaOnc: Sat #ASCO16 poster 9548,M Rohlfs: BRAF +/ -MEK inhibition plus PD-1 checkpoint blockade for treatment of metastatic #me…
RT @MedscapeDerm: #ASCO16: findings from NEMO, other #Melanoma highlights. wb.md/1TYyVZH
#ASCO16 news about #melanoma #skincancer
In which patients with #melanoma should sentinel lymph node biopsy be pursued? https://t.co/WeFysq4uIg #ASCO16
— ASCO (@ASCO) June 4, 2016
#ASCO16 news about metastatic #melanoma #skincancer
The Evolving Treatment Landscape of Metastatic #Melanoma: From Ipilimumab to New Checkpoint Inhibitors https://t.co/yypM2sZmUP #ASCO16
— ASCO (@ASCO) June 4, 2016
#ASCO16 news about metastatic #melanoma #skincancer
Examining the role of combination #immunotherapy treatment for patients w/ metastatic melanoma https://t.co/K4HkHD8tEj #ASCO16
— ASCO (@ASCO) June 4, 2016
RT @PoschChristian: ASCO – the Woodstock of oncology. #ASCO16 #cancer #melanoma #pd1 pic.twitter.com/dYtLBKDn0h
About #asco16 Educational Book. Among others #melanoma #skincancer
Over 250 oncologists and researchers contributed to the #ASCO16 Educational Book. Have you read it yet? https://t.co/aKanDBqqsc
— ASCO (@ASCO) June 5, 2016